[1] Paradisi S, Sacchetti B, Balduzzi M, et al.Astrocyte modulation of in vitro betaamyloid neurotoxicity. Glia,2004,46(3): 252260.
[2] Kato H, Araki T, Imai Y, et al. Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)()2propyloctanoic acid (ONO2506) in an MPTPmouse model of Parkinson’s disease. J Neurol Sci, 2003,208(12):915.
[3] Kasischke K A, Vishwasrao H D, Fisher P J, et al. Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science, 2004 ,305(5680):99103.
[4] Hama H, Hara C, Yamaguchi K, et al. PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes. Neuron, 2004 ,41(3):405415.
[5] Brown D R. Neurons depend on astrocytes in a coculture system for protection from glutamate toxicity. Mol Cell Neurosci, 1999,13(5):379389.
[6] Amano S, Ohashi M, Ishiko T, et al. Humoral factors derived from glial cells protect cultured neuroblastoma cells against glutamate toxicity. Brain Res, 1994, 645(12):347350.
[7] Langeveld C H, Jongenelen C A, Schepens E, et al. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci Lett, 1995,192(1): 1316.
[8] Bronstein D M, PerezOtano I, Sun V, et al. Gliadependent neurotoxicity and neuroprotection in mesencephalic cultures.Brain Res, 1995,704(1):112116.
[9] Saura J, Pares M, Bove J, et al. Intranigral infusion of interleukin1[beta] activates astrocytes and protects from subsequent 6hydroxydopamine neurotoxicity. J Neurochem, 2003,85(3):651661.
[10] Giordano G, Kavanagh T J, Costa L G. Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE71.Neurotoxicology, 2009 ,30(2):326329.
[11] Sandhu J K, Gardaneh M, Iwasiow R, et al. Astrocytesecreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity.Neurobiol Dis, 2009, 33(3):405414.
[12] Anderl J L, Redpath S, Ball A J. A neuronal and astrocyte coculture assay for high content analysis of neurotoxicity. J Vis Exp, 2009,27:1173.
[13] Satoh T, Okamoto S I, Cui J, et al. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophillic phaseⅡ inducers. Proc Natl Acad Sci USA,2006, 103(3):768773.
[14] Kraft A D, Johnson D A, Johnson J A. Nuclear factor E2related factor 2dependent antioxidant reoponse element activation by tertButylhydroquinone and Sulforphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci, 2004,24(5):11011112.
[15] Kobayashi A, Ito E, Toki T, et al. Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. J Biol Chem, 1999,274(10):64436452.
[16] Derjuga A, Gourley T S, Holm T M, et al. Complexity of CNC transcription factors as revealed by gene targeting of the Nrf3 locus. Mol Cell Biol, 2004,24(8):32863294.
[17] Sankaranarayanan K, Jaiswal A K. Nrf3 Negatively Regulates Antioxidantresponse Elementmediated Expression and Antioxidant Induction of NAD(P)H:Quinone Oxidoreductase1 Gene. J Biol Chem, 2004,279(9):5081050817.
[18] Long D J, Waikel R L, Wang X J, et al. NAD(P)H: quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12dimethylbenz[a]anthraceneinduced carcinogenesis in mouse skin. J Nati Cancer Inst, 2001,93(5):11661170.
[19] Duffy S, So A, Murphy T H. Activation of endogenous antioxidant defenses in neuronal cells prevents free radicalmediated damage. J Neurochem, 1998,71(1):6977. |